1. Freeman RB Jr. The 'indirect' effects of cytomegalovirus infection. Am J Transplant 2009;9(11):2453-8 [
DOI:10.1111/j.1600-6143.2009.02824.x] [
PMID]
2. Van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 2001;33 Suppl 1:S32-S37. [
DOI:10.1086/320902] [
PMID]
3. De Keyzer K, Van Laecke S, Peeters P, Vanholder R. Human cytomegalovirus and kidney transplantation: a clinician's update. Am J Kidney Dis 2011;58(1):118-26. [
DOI:10.1053/j.ajkd.2011.04.010] [
PMID]
4. Humar A, Snydman D. AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S78-S86. [
DOI:10.1111/j.1600-6143.2009.02897.x] [
PMID]
5. Saeed B. Pediatric renal transplantation. Int J Organ Transplant Med 2012;3(2):62-73. [
PMID] [
PMCID]
6. Opelz G, Döhler B. Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients. Transplantation 2015;99(6):1197-1202. [
DOI:10.1097/TP.0000000000000522] [
PMID]
7. Baranwal AK, Mehra NK. Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation. Front Immunol 2017;8:182. [
DOI:10.3389/fimmu.2017.00182]
8. Risti M, Bicalho MD. MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome? Front Immunol 2017;8:179. [
DOI:10.3389/fimmu.2017.00179] [
PMID] [
PMCID]
9. Luo L, Lu J, Wei L, Long D, Guo JY, Shan J, et al. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 2010;11:91. [
DOI:10.1186/1471-2121-11-91] [
PMID] [
PMCID]
10. Tong HV, Toan NL, Song LH, Bock CT, Kremsner PG, Velavan TP. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants. J Viral Hepat 2013;20(10):687-98. [
DOI:10.1111/jvh.12089] [
PMID]
11. González S, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol 2006;298:121-38. [
DOI:10.1007/3-540-27743-9_6] [
PMID]
12. Seidel E, Le VT, Bar-On Y, Tsukerman P, Enk J, Yamin R, et al. Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells. Cell Rep 2015;10(6):968-82. [
DOI:10.1016/j.celrep.2015.01.029] [
PMID] [
PMCID]
13. Raache R, Belanteur K, Amroun H, Benyahia A, Heniche A, Azzouz M, et al. Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population. Clin Vaccine Immunol 2012;19(4):557-61. [
DOI:10.1128/CVI.05473-11] [
PMID] [
PMCID]
14. Choy MK, Phipps ME. MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 2010;16(3):97-106. [
DOI:10.1016/j.molmed.2010.01.002] [
PMID]
15. Wang Q, Zhou X. Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases. Open Rheumatol J 2015;9:94-100. [
DOI:10.2174/1874312901409010094] [
PMID] [
PMCID]
16. Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001;53(4):279-87. [
DOI:10.1007/s002510100325] [
PMID]
17. Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 2006;67(3):141-4. [
DOI:10.1016/j.humimm.2006.02.019] [
PMID]
18. Isernhagen A, Malzahn D, Bickeböller H, Dressel R. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks. Front Immunol 2016;7:588. [
DOI:10.3389/fimmu.2016.00588] [
PMID] [
PMCID]
19. López-Oliva MO, Flores J, Madero R, Escuin F, Santana MJ, Bellón T, et al. Cytomegalovirus infection after kidney transplantation and long-term graft loss. La infección por citomegalovirus postrasplante renal y pérdida del injerto a largo plazo. Nefrologia 2017;37(5):515-25. [
DOI:10.1016/j.nefro.2016.11.018] [
PMID]
20. Morran MP, Omenn GS, Pietropaolo M. Immunology and genetics of type 1 diabetes. Mt Sinai J Med 2008;75(4):314-27. [
DOI:10.1002/msj.20052] [
PMID]
21. Michita RT, Chies JA, Schramm S, Horn PA, Heinemann FM, Wunsch A, et al. A Valine Mismatch at Position 129 of MICA Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas⁻Kidney Transplantation Recipients. Int J Mol Sci 2018;19(9):2618. [
DOI:10.3390/ijms19092618] [
PMID] [
PMCID]
22. Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 2005;66(10):1057-61. [
DOI:10.1016/j.humimm.2005.09.004] [
PMID]
23. López-Hernández R, Valdés M, Lucas D, Campillo JA, Martínez-Garcia P, Salama H, et al. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol 2010;71(5):512-4. [
DOI:10.1016/j.humimm.2010.02.003] [
PMID]
24. Yoshida K, Komai K, Shiozawa K, Mashida A, Horiuchi T, Tanaka Y, et al. Role of the MICA polymorphism in systemic lupus erythematosus. Arthritis Rheum 2011;63(10):3058-66. [
DOI:10.1002/art.30501] [
PMID]
25. Douik H, Chaaben AB, Romdhane NA, Romdhane HB, Mamoghli T, Fortier C, et al. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol 2009;70(1):45-8. [
DOI:10.1016/j.humimm.2008.10.008] [
PMID]
26. Boukouaci W, Busson M, Peffault de Latour R, Rocha V, Suberbielle C, Bengoufa D, et al. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Blood 2009;114(25):5216-24. [
DOI:10.1182/blood-2009-04-217430] [
PMID]
27. Zhao J, Jiang Y, Lei Y, Zou K, Wang C, Huang S, et al. Functional MICA-129 polymorphism and serum levels of soluble MICA are correlated with ulcerative colitis in Chinese patients. J Gastroenterol Hepatol 2011;26(3):593-8. [
DOI:10.1111/j.1440-1746.2010.06524.x] [
PMID]
28. Ouni N, Ben Chaaben A, Kablouti G, Lajnef M, Ayari F, Abaza H, et al. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk. Immunol Invest 2017;46(6):603-14. [
DOI:10.1080/08820139.2017.1336175] [
PMID]
29. Mariaselvam CM, Boukouaci W, Charron D, Krishnamoorthy R, Tamouza R, Misra DP, et al. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population. Int J Rheum Dis 2018;21(3):656-63. [
DOI:10.1111/1756-185X.13138] [
PMID]